enGene Holdings Inc. (ENGN)
(Delayed Data from NSDQ)
$5.83 USD
-0.13 (-2.18%)
Updated Dec 20, 2024 04:00 PM ET
After-Market: $5.92 +0.09 (1.54%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ENGN 5.83 -0.13(-2.18%)
Will ENGN be a Portfolio Killer in December?
Zacks Investment Research is releasing its prediction for ENGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ENGN
enGene Holdings Inc. (ENGN) Upgraded to Strong Buy: Here's Why
Here's Why enGene Holdings Inc. (ENGN) is Poised for a Turnaround After Losing -16.9% in 4 Weeks
ENGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ENGN
Engene Holdings Faces Regulatory Challenges and Business Risks Amid Clinical Trial Hurdles
Analysts Offer Insights on Real Estate Companies: Federal Realty (FRT), Real Brokerage (REAX) and enGene Holdings (ENGN)
Promising Potential of enGene Holdings’ Detalimogene Voraplasmid in NMIBC Treatment: A Compelling Investment Opportunity
FedEx to separate Freight unit, Nike reports Q2 beat: Morning Buzz
FedEx to separate Freight unit, Nike reports Q2 beat: Morning Buzz